Offerings // BridgeBio Pharma, Inc.

BBIO offering history

Every offering-related filing in BridgeBio Pharma, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 820 filings back to Jun 19, 2018.

Last executed offering

Jul 2, 2026

8-K — priced deal (shares or notes)

Last registration (announced)

Jul 24, 2026

S-3ASR — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Aug 14, 2026	424B7 →	UPDATE	Resale prospectus — existing holders registering to sell
Jul 24, 2026	S-3ASR →	REGISTERED	Automatic shelf registration — effective immediately (large filers)
Jul 2, 2026	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
May 8, 2026	S-3ASR →	REGISTERED	Automatic shelf registration — effective immediately (large filers)
Jan 21, 2026	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Feb 28, 2025	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Mar 6, 2024	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Mar 4, 2024	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Nov 2, 2023	S-3ASR →	REGISTERED	Automatic shelf registration — effective immediately (large filers)
Sep 25, 2023	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jul 26, 2023	S-3ASR →	REGISTERED	Automatic shelf registration — effective immediately (large filers)
May 4, 2023	S-3ASR →	REGISTERED	Automatic shelf registration — effective immediately (large filers)
Mar 9, 2023	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Mar 6, 2023	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 16, 2021	424B7 →	UPDATE	Resale prospectus — existing holders registering to sell
Feb 11, 2021	424B7 →	UPDATE	Resale prospectus — existing holders registering to sell
Jan 29, 2021	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Dec 15, 2020	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Dec 15, 2020	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jul 28, 2020	S-3ASR →	REGISTERED	Automatic shelf registration — effective immediately (large filers)
Jul 7, 2020	S-3ASR →	REGISTERED	Automatic shelf registration — effective immediately (large filers)
Mar 10, 2020	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jun 28, 2019	424B4 →	EXECUTED	Final prospectus — offering priced (typical for IPOs and marketed share deals)
Jun 26, 2019	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Jun 26, 2019	S-1MEF →	REGISTERED	S-1MEF registration — capacity to sell shares, not a sale yet
Jun 26, 2019	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jun 24, 2019	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Jun 17, 2019	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Jun 11, 2019	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
May 24, 2019	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet

BBIO offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full BBIO workspace →

BBIO offering FAQ

When did BBIO last execute an offering?

Per SEC filings, BridgeBio Pharma, Inc.'s most recent priced offering document is a 8-K filed 2026-07-02. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did BBIO last announce or register an offering?

The most recent registration is a S-3ASR filed 2026-07-24. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.